The analysis of global diuretic medicine use in 2024 shows Costa Rica leading with a significant usage of 59.7 units per thousand persons per day, followed by Portugal and Finland at 53.6 and 49.6 units, respectively. While New Zealand and Estonia show no significant change, countries like Costa Rica, Portugal, and Greece have experienced slight positive year-on-year growth in usage. Conversely, Belgium and Luxembourg experienced notable declines, with Belgium plummeting by 3.13% and Luxembourg by 3.58% in 2023. Over the past two years, varied usage patterns are evident with high fluctuations in about half of these countries.
Looking forward, watch for innovations in medical treatment, demographic changes, and health policy reforms which may alter usage patterns. Aging populations and increasing prevalence of lifestyle-related diseases could drive demand, while emerging health applications and telehealth might influence accessibility and prescription rates of diuretic medicines worldwide.
Top countries in Diuretic Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Costa Rica | 59.7 | 2023 | +21.34% | +1.07% | View data |
| 2 | 2 Portugal | 53.6 | 2023 | +0.94% | +0.53% | View data |
| 3 | 3 Finland | 49.6 | 2023 | -0.6% | -0.71% | View data |
| 4 | 4 New Zealand | 43.5 | 2023 | +0.69% | View data | |
| 5 | 5 Hungary | 38.6 | 2023 | +0.26% | -0.91% | View data |
| 6 | 6 Slovenia | 33 | 2023 | -0.9% | -1.17% | View data |
| 7 | 7 Belgium | 31.9 | 2023 | -2.15% | -3.13% | View data |
| 8 | 8 Greece | 30.9 | 2023 | 0% | +1.21% | View data |
| 9 | 9 Estonia | 27.1 | 2023 | +1.12% | +0.6% | View data |
| 10 | 10 Luxembourg | 25 | 2023 | -4.21% | -3.58% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...